Registro completo de metadatos
Campo DC Valor Lengua/Idioma
dc.creatorMorales López, Soraya Eugenia-
dc.creatorTaverna, Costanza G.-
dc.creatorBosco Borgeat, María Eugenia-
dc.creatorMaldonado, Nuria Ivana-
dc.creatorVivot, Walter-
dc.creatorSzusz, Wanda-
dc.creatorGarcia, Guillermo Manuel-
dc.creatorCórdoba, Susana Beatríz-
dc.date2019-02-19T18:31:19Z-
dc.date2019-02-19T18:31:19Z-
dc.date2016-12-
dc.date2019-02-12T14:29:04Z-
dc.date.accessioned2019-04-29T15:42:40Z-
dc.date.available2019-04-29T15:42:40Z-
dc.date.issued2016-12-
dc.identifierMorales López, Soraya Eugenia; Taverna, Costanza G.; Bosco Borgeat, María Eugenia; Maldonado, Nuria Ivana; Vivot, Walter; et al.; Candida glabrata species complex prevalence and antifungal susceptibility testing in a culture collection: First description of Candida nivariensis in Argentina; Springer; Mycopathologia; 181; 11-12; 12-2016; 871-878-
dc.identifier0301-486X-
dc.identifierhttp://hdl.handle.net/11336/70471-
dc.identifier1573-0832-
dc.identifierCONICET Digital-
dc.identifierCONICET-
dc.identifier.urihttp://rodna.bn.gov.ar:8080/jspui/handle/bnmm/300085-
dc.descriptionThe presence of the cryptic species belonging to the Candida glabrata complex has not been studied in Argentina. We analyzed a collection of 117 clinical isolates of C. glabrata complex belonging to a National Culture Collection of Instituto Nacional de Microbiología “Dr. Carlos G. Malbrán” from Argentina (40 isolates from blood samples, 18 from other normally sterile sites, 20 from vagina, 14 from urine, 7 from oral cavity, 3 from catheter, 1 from a stool sample and 14 isolates whose clinical origin was not recorded). The aims of this work were to determine the prevalence of the cryptic species Candida nivariensis and Candida bracarensis and to evaluate the susceptibility profile of isolates against nine antifungal drugs. Identification was carried out by using classical phenotypic tests, CHROMagar™ Candida, PCR and MALDI-TOF. The minimal inhibitory concentrations of amphotericin B, 5-fluorocytosine, fluconazole, itraconazole, voriconazole, ketoconazole, posaconazole, caspofungin and anidulafungin were determined according to the EDef 7.3 (EUCAST) reference document. Of the 117 isolates, 114 were identified as C. glabrata and three as C. nivariensis by using PCR and MALDI-TOF. There were no major differences between C. nivariensis and C. glabrata susceptibility profiles. No resistant strains were found to echinocandins. We have found that the percentage of C. nivariensis in our culture collection was 2.56. This is the first description of C. nivariensis in Argentina, and data obtained could contribute to the knowledge of the epidemiology of this cryptic species.-
dc.descriptionFil: Morales López, Soraya Eugenia. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina-
dc.descriptionFil: Taverna, Costanza G.. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina-
dc.descriptionFil: Bosco Borgeat, María Eugenia. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina-
dc.descriptionFil: Maldonado, Nuria Ivana. Laboratorios Domeq y Lafage; Argentina-
dc.descriptionFil: Vivot, Walter. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina-
dc.descriptionFil: Szusz, Wanda. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina-
dc.descriptionFil: Garcia, Guillermo Manuel. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro Científico Tecnológico Conicet - Santa Fe; Argentina. Universidad Nacional del Litoral. Facultad de Bioquímica y Ciencias Biológicas; Argentina-
dc.descriptionFil: Córdoba, Susana Beatríz. Dirección Nacional de Instituto de Investigación. Administración Nacional de Laboratorio e Instituto de Salud “Dr. C. G. Malbrán”; Argentina-
dc.formatapplication/pdf-
dc.formatapplication/pdf-
dc.formatapplication/pdf-
dc.languageeng-
dc.publisherSpringer-
dc.relationinfo:eu-repo/semantics/altIdentifier/doi/https://dx.doi.org/10.1007/s11046-016-0052-1-
dc.relationinfo:eu-repo/semantics/altIdentifier/url/https://link.springer.com/article/10.1007/s11046-016-0052-1-
dc.rightsinfo:eu-repo/semantics/restrictedAccess-
dc.rightshttps://creativecommons.org/licenses/by-nc-sa/2.5/ar/-
dc.sourcereponame:CONICET Digital (CONICET)-
dc.sourceinstname:Consejo Nacional de Investigaciones Científicas y Técnicas-
dc.sourceinstacron:CONICET-
dc.subjectANTIFUNGAL SUSCEPTIBILITY TESTING-
dc.subjectCANDIDA BRACARENSIS-
dc.subjectCANDIDA GLABRATA COMPLEX-
dc.subjectCANDIDA NIVARIENSIS-
dc.subjectMALDI-TOF-
dc.subjectYEAST IDENTIFICATION-
dc.subjectOtras Ciencias Biológicas-
dc.subjectCiencias Biológicas-
dc.subjectCIENCIAS NATURALES Y EXACTAS-
dc.titleCandida glabrata species complex prevalence and antifungal susceptibility testing in a culture collection: First description of Candida nivariensis in Argentina-
dc.typeinfo:eu-repo/semantics/article-
dc.typeinfo:eu-repo/semantics/publishedVersion-
dc.typeinfo:ar-repo/semantics/articulo-
Aparece en las colecciones: CONICET

Ficheros en este ítem:
No hay ficheros asociados a este ítem.